Lundbeck Q3 2019 Financial Results

Lundbeck in brief SPECIALIZED IN BRAIN HEALTH ➤ ~70 years of expertise in CNS ➤ Among the first to develop and market antipsychotics 70 yrs REVENUE (FY2018) -60% generated in North America China 2nd largest market -$2.8bn GLOBAL PRESENCE ➤ Headquartered in Denmark ➤ Operating in 50+ countries 50+ HISTORY Lundbeck was founded by Hans Lundbeck in 1915 in Copenhagen 1915 OWNERSHIP Largest shareholder is the Lundbeck Foundation, which annually grants DKK 400-500 million to research ● 70% 3 EMPLOYEES -5,500 Lundbeck

View entire presentation